Tobacco Plants Engineered to Produce Five Psychedelic Compounds

Bottom line: Engineered tobacco plants may produce psychedelic compounds sustainably.

Tobacco Plants Engineered to Produce Psychedelic Compounds, Easing Pressure on Natural Sources

Scientists at the Weizmann Institute of Science in Israel have successfully engineered tobacco plants to produce five different psychedelic tryptamines, including psilocybin and psilocin, the active compounds found in “magic mushrooms.” This breakthrough has the potential to ease the pressure on overharvested natural sources, such as psilocybin-producing mushrooms, by providing a sustainable and efficient alternative for production.

The team, led by the Aharoni Lab, used a temporary genetic engineering technique called agroinfiltration to introduce nine genes from plants, fungi, and animals into the tobacco plants. The plants were able to biosynthesize the five psychedelic tryptamines, including DMT, bufotenin, and 5-MeO-DMT, which is associated with the Colorado River toad. Notably, the researchers also engineered enzymes to produce non-natural analogs of these compounds, which could have potential therapeutic applications. For instance, one of the engineered enzymes was able to produce a novel analog of psilocybin, which could potentially have improved pharmacological properties.

The study, published in Science Advances, demonstrates the power of metabolic engineering and rational protein design in creating novel biosynthetic pathways in plants. By reconstructing the full biosynthetic pathways of the five psychedelic tryptamines in a single plant assay, the researchers established a versatile platform for their production in plants. This achievement is particularly striking, given that the biosynthetic pathways involved are complex and involve multiple enzymes and intermediates. In fact, the researchers found that the tobacco plants were able to produce the psychedelic tryptamines with yields that were comparable to those found in natural sources, highlighting the potential of this approach for large-scale production.

The Potential for Sustainable Manufacturing

Growing these plants in greenhouses could provide a sustainable and efficient alternative to traditional methods, minimizing the environmental impact and alleviating the pressure on natural sources. For example, the cultivation of psilocybin-producing mushrooms often requires large amounts of land, water, and labor, resulting in significant environmental degradation. In contrast, the production of psychedelic tryptamines in tobacco plants could be done in a controlled environment, reducing the risk of overharvesting and habitat destruction.

The Importance of Basic Science Research

This study is a basic science experiment, and the results do not prove the safety or efficacy of these compounds in humans. The researchers are exploring their potential applications, not claiming therapeutic benefits. More research is needed to fully realize their potential. It’s also important to note that the study does not provide any evidence for the safety or efficacy of these compounds in humans, and the compounds produced are controlled substances, regulated by law.

Frequently Asked Questions

Q: Are these compounds safe for human consumption? A: The study does not provide any evidence for the safety or efficacy of these compounds in humans. Q: Can I grow these plants at home? A: No, the plants used in this study are genetically engineered and require specialized equipment and expertise to grow. Q: Are these compounds legal? A: The compounds produced in this study are controlled substances and are regulated by law.

Sources

Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants Classic psychedelics: past uses, present trends, future possibilities Biosynthesis of kratom opioids

Educational Disclaimer

This article is for informational and educational purposes only. It is not medical advice, mental health advice, diagnosis, treatment guidance, or a recommendation to use any substance, supplement, therapy, or protocol.

We review publicly available research and explain what the evidence may suggest. Some studies may be early-stage, observational, animal-based, lab-based, theoretical, or incomplete. Always consult a qualified professional before making health-related decisions.

If you or someone you know is struggling, you are not alone. In the US, call or text 988 (Suicide & Crisis Lifeline). Elsewhere, contact your local emergency or crisis service.

Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.